JP2000512844A5 - - Google Patents

Download PDF

Info

Publication number
JP2000512844A5
JP2000512844A5 JP1998502456A JP50245698A JP2000512844A5 JP 2000512844 A5 JP2000512844 A5 JP 2000512844A5 JP 1998502456 A JP1998502456 A JP 1998502456A JP 50245698 A JP50245698 A JP 50245698A JP 2000512844 A5 JP2000512844 A5 JP 2000512844A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998502456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000512844A (ja
Filing date
Publication date
Priority claimed from FR9608243A external-priority patent/FR2750866B1/fr
Application filed filed Critical
Publication of JP2000512844A publication Critical patent/JP2000512844A/ja
Publication of JP2000512844A5 publication Critical patent/JP2000512844A5/ja
Pending legal-status Critical Current

Links

JP10502456A 1996-06-27 1997-06-25 ベクターとして鳥類の感染性喉頭気管炎ウイルスを用いた鳥類用組換え生ワクチン Pending JP2000512844A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/08243 1996-06-27
FR9608243A FR2750866B1 (fr) 1996-06-27 1996-06-27 Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
PCT/FR1997/001138 WO1997049826A1 (fr) 1996-06-27 1997-06-25 Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire

Publications (2)

Publication Number Publication Date
JP2000512844A JP2000512844A (ja) 2000-10-03
JP2000512844A5 true JP2000512844A5 (en:Method) 2004-12-09

Family

ID=9493649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10502456A Pending JP2000512844A (ja) 1996-06-27 1997-06-25 ベクターとして鳥類の感染性喉頭気管炎ウイルスを用いた鳥類用組換え生ワクチン

Country Status (13)

Country Link
US (1) US6153199A (en:Method)
EP (1) EP0914458A1 (en:Method)
JP (1) JP2000512844A (en:Method)
AR (1) AR008620A1 (en:Method)
AU (1) AU739374B2 (en:Method)
CO (1) CO4700303A1 (en:Method)
FR (1) FR2750866B1 (en:Method)
ID (1) ID18351A (en:Method)
MA (1) MA24222A1 (en:Method)
PE (1) PE52599A1 (en:Method)
TN (1) TNSN97109A1 (en:Method)
WO (1) WO1997049826A1 (en:Method)
ZA (1) ZA975618B (en:Method)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
DE69836557T2 (de) * 1997-10-03 2007-09-20 Zeon Corp. Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden
AR031405A1 (es) * 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
JP2002356441A (ja) * 2001-03-15 2002-12-13 Akzo Nobel Nv 組換え伝染性喉頭気管炎ウイルスワクチン
US7314715B2 (en) * 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
SG148848A1 (en) 2001-11-16 2009-01-29 Biogen Idec Inc Polycistronic expression of antibodies
EP2390352A1 (en) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systems and methods for improving protein and milk production of dairy herds
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
WO2005049794A2 (en) 2003-11-13 2005-06-02 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
EP1718770B1 (en) 2004-02-19 2011-05-25 The Governors of the University of Alberta Leptin promoter polymorphisms and uses thereof
EP2198881A1 (en) 2005-04-25 2010-06-23 Merial Limited Nipah virus vaccines
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
EP1951751B1 (en) 2005-11-14 2017-11-01 Merial, Inc. Gene therapy for renal failure
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
JP5797636B2 (ja) 2009-04-03 2015-10-21 メリアル リミテッド ニューカッスル病ウイルスをベクターとするトリワクチン
DK2327764T3 (da) 2009-11-30 2012-04-02 United Cancer Res Inst Ny klon af Newcastle disease-virus, dens fremstilling og dens anvendelse ved medicinsk behandling af cancer
AR079767A1 (es) 2009-12-28 2012-02-15 Merial Ltd Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo
BR112013002525A2 (pt) * 2010-08-02 2016-05-31 Univ Georgia vírus da laringotraqueíte infecciosa (iltv) modificado e usos do mesmo
WO2012030720A1 (en) 2010-08-31 2012-03-08 Merial Limited Newcastle disease virus vectored herpesvirus vaccines
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
US20140287931A1 (en) 2011-04-04 2014-09-25 Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
EP2694677A2 (en) 2011-04-04 2014-02-12 Netherland Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
AU2012245395A1 (en) 2011-04-20 2013-11-14 Merial, Inc. Adjuvanted rabies vaccine with improved viscosity profile
CA2834288A1 (en) 2011-04-25 2012-11-01 Advanced Bioscience Laboratories, Inc. Truncated hiv envelope proteins (env), methods and compositions related thereto
CA2837375C (en) 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
JP6041361B2 (ja) 2011-08-12 2016-12-07 メリアル インコーポレイテッド 生物学的製品、特にはワクチンの真空保存
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
EP2922465A4 (en) 2012-11-21 2016-07-06 Cardiomems Inc DEVICES, SYSTEMS AND METHODS FOR ASSESSING AND TREATING PULMONARY ARTERIAL HYPERTENSION (PAH)
WO2014164697A1 (en) 2013-03-12 2014-10-09 Merial Limited Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
US9198908B2 (en) 2013-03-15 2015-12-01 St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux Ii”) Methods for the treatment of cardiovascular conditions
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
WO2016073410A1 (en) 2014-11-03 2016-05-12 Merial, Inc. Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
PH12017502380B1 (en) 2015-06-23 2022-10-26 Merial Inc Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434721B1 (en) * 1988-09-13 2000-03-15 Merial Viral nucleotide sequences
WO1992003554A1 (en) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Infectious laryngotracheitis virus vaccine
WO1993025655A1 (en) * 1992-06-12 1993-12-23 Genencor International, Inc. Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric
AU2946395A (en) * 1994-06-30 1996-01-25 Board of Regents of the University of Illinois, The Recombinant infectious laryngotracheitis virus and vaccine
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
WO1996029396A1 (en) * 1995-03-23 1996-09-26 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof

Similar Documents

Publication Publication Date Title
JP2000502280A5 (en:Method)
JP2000501771A5 (en:Method)
JP2000501599A5 (en:Method)
JP2000501018A5 (en:Method)
JP2000500076A5 (en:Method)
JP2000501324A5 (en:Method)
JP2000500055A5 (en:Method)
JP2000503844A5 (en:Method)
JP2000502472A5 (en:Method)
JP2000501825A5 (en:Method)
JP2000501338A5 (en:Method)
JP2000500874A5 (en:Method)
JP2000502425A5 (en:Method)
JP2000502485A5 (en:Method)
JP2000501774A5 (en:Method)
JP2000500912A5 (en:Method)
JP2000502570A5 (en:Method)
JP2001510338A5 (en:Method)
JP2000501876A5 (en:Method)
JP2000501744A5 (en:Method)
JP2000501229A5 (en:Method)
JP2000511339A5 (en:Method)
JP2000502316A5 (en:Method)
JP2000500857A5 (en:Method)
JP2000502714A5 (en:Method)